ISRG

Prezzo Intuitive Surgical Inc

Closed
ISRG
$450,69
-$2,68(-0,59%)

*Data last updated: 2026-05-10 01:54 (UTC+8)

As of 2026-05-10 01:54, Intuitive Surgical Inc (ISRG) is priced at $450,69, with a total market cap of $159,39B, a P/E ratio of 70,77, and a dividend yield of 0,00%. Today, the stock price fluctuated between $447,00 and $457,05. The current price is 0,82% above the day's low and 1,39% below the day's high, with a trading volume of 2,39M. Over the past 52 weeks, ISRG has traded between $439,05 to $491,15, and the current price is -8,23% away from the 52-week high.

ISRG Key Stats

Yesterday's Close$453,49
Market Cap$159,39B
Volume2,39M
P/E Ratio70,77
Dividend Yield (TTM)0,00%
Diluted EPS (TTM)8,39
Net Income (FY)$2,85B
Revenue (FY)$10,06B
Earnings Date2026-07-28
EPS Estimate2,48
Revenue Estimate$2,82B
Shares Outstanding351,48M
Beta (1Y)1.509

About ISRG

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
SectorHealthcare
IndustryMedical - Instruments & Supplies
CEODavid J. Rosa
HeadquartersSunnyvale,CA,US
Employees (FY)17,02K
Average Revenue (1Y)$591,31K
Net Income per Employee$167,79K

Intuitive Surgical Inc (ISRG) FAQ

What's the stock price of Intuitive Surgical Inc (ISRG) today?

x
Intuitive Surgical Inc (ISRG) is currently trading at $450,69, with a 24h change of -0,59%. The 52-week trading range is $439,05–$491,15.

What are the 52-week high and low prices for Intuitive Surgical Inc (ISRG)?

x

What is the price-to-earnings (P/E) ratio of Intuitive Surgical Inc (ISRG)? What does it indicate?

x

What is the market cap of Intuitive Surgical Inc (ISRG)?

x

What is the most recent quarterly earnings per share (EPS) for Intuitive Surgical Inc (ISRG)?

x

Should you buy or sell Intuitive Surgical Inc (ISRG) now?

x

What factors can affect the stock price of Intuitive Surgical Inc (ISRG)?

x

How to buy Intuitive Surgical Inc (ISRG) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

Hot Posts su Intuitive Surgical Inc (ISRG)

MrDecoder

MrDecoder

3 ore fa
Shares of **Medtronic** (MDT 2.48%) are down 40% from their 2021 high. The dividend yield is a historically high 3.6%. Although this medical device maker is deeply unloved, now could be a good time for savvy investors to start adding it to their portfolios. Here's why. Medtronic is revamping its business ----------------------------------- Medtronic is facing headwinds. Growth and profitability have both been weak spots. But management is attempting to improve its business performance. Image source: Getty Images. On the profitability side, the medical device maker has been readjusting its product portfolio to focus on its highest margin businesses. Included in that process is the spin-off of the company's diabetes division as **MiniMed** (MMED 1.36%). That division was growing quickly, but it had lower margins, so the spin-off is expected to improve Medtronic's margins and be immediately accretive to Medtronic's earnings. On the growth side, the company has several new products it is bringing to market after a dry spell. The most notable is the company's Hugo surgical robot. **Intuitive Surgical** (ISRG 0.81%) has benefited for years from strong demand for its da Vinci surgical robot. There's good reason to believe Hugo will be well received, too, given Medtronic's deep customer relationships in the healthcare sector. The company has also been acquiring smaller companies with interesting technology, in an effort to further bolster its product pipeline for the future. Medtronic is paying you well to wait ------------------------------------ Basically, Medtronic is putting the puzzle pieces together to get back on a stronger footing. When that happens, Wall Street is likely to reward the stock with a higher valuation. While you wait for that to happen, you can collect the stock's well-above-market yield. But there's more to the dividend story than just the yield. Expand NYSE: MDT --------- Medtronic Today's Change (-2.48%) $-1.93 Current Price $76.03 ### Key Data Points Market Cap $98B Day's Range $75.92 - $78.27 52wk Range $75.91 - $106.33 Volume 229K Avg Vol 8.8M Gross Margin 59.59% Dividend Yield 3.73% Medtronic's dividend has been increased annually for 48 consecutive years. While the last few dividend increases have been little more than token hikes, the streak is still intact. And the company is just two years away from hitting Dividend King status. A company can't increase its dividend for this long without successfully working through difficult periods. This is just one of the hard times. If history is any guide, Medtronic will get through this and back on a better track. Buy Medtronic now, before the business improves ----------------------------------------------- There's no way to know exactly when Wall Street starts to see Medtronic in a better light. However, if you buy the stock now, you will be there when the business trends turn positive again. And, when that does happen, you'll likely see a return to faster dividend growth, as well. This is why savvy long-term investors should consider buying Medtronic now, while the stock is still beaten down.
0
0
0
0
MrDecoder

MrDecoder

5 ore fa
Breakfast News: Markets Breathe Easy on Iran Truce -------------------------------------------------- ### April 22, 2026 | Tuesday's Markets | | --- | | **S&P 500** 7,064 (-0.63%) | | **Nasdaq** 24,260 (-0.59%) | | **Dow** 49,149 (-0.59%) | | **Bitcoin** $75,602 (-1.15%) | Source: Image created by Jester AI. 1. Futures up as Iran Ceasefire Extended ---------------------------------------- Stock market futures were higher this morning, after President Trump said he's extending the ceasefire until "discussions are concluded, one way or the other" – following a request from peace broker Pakistan, until "leaders and representatives can come up with a unified proposal." In early trading, S&P 500 futures gained 0.5%, with Nasdaq futures up 0.7%. * **"I have ... directed our military to continue the blockade":** There's no letup of pressure on ships connected with Iran yet, as the Strait of Hormuz remains closed after Iran accused the U.S. of breaking its commitments. * **"Biggest oil supply disruption on record" – Reuters:** Despite the threat of immediate escalation subsiding, oil futures barely moved, held back by the growing uncertainty. Benchmark Brent Crude fell just 0.6% this morning to a fraction below $98, with WTI down 1% at around $89. 2. After-Market Results Roundup for Fool Recs --------------------------------------------- * **Intuitive Surgical** (ISRG 0.81%) gained a little over 1% overnight, on the back of a 23% jump in first-quarter revenue year over year (YoY). CFO Jamie Samath noted oil prices had not significantly impacted Q1, but are expected "to have a greater unfavorable impact in the remainder of the year" on the _Rule Breakers_ recommendation. * **EQT** (EQT 0.46%), beating the S&P 500 by 11% since its 2024 _Hidden Gems_ rec, saw a modest price rise around 0.4% before the market opened, even though the natural gas producer posted a 97.5% YoY jump in non-GAAP earnings per share – with free cash flow up 69% and net debt falling $2 billion. * **Interactive Brokers** (IBKR +0.85%), recommended in _Stock Advisor_ by Team Hidden Gems, reached 4.75 million clients at the end of the quarter, up 31%, boosting non-GAAP revenue 20% YoY. We had no explicit full-year guidance, but investors should watch margins. The stock rose around 1% pre-market. 3. Today's Selected Stock Advisor Earnings ------------------------------------------ * **CME Group** (CME 1.97%) reported new highs across the board in its first quarter of fiscal 2026, with revenue climbing to $1.9 billion and net income reaching $1.2 billion. Chairman and CEO Terry Duffy said “Robust demand for our products drove Q1 average daily volume up 22% to a record 36.2 million contracts, including records in all six asset classes.” The stock barely moved in response. * **Lam Research** (LRCX +2.53%) will reveal Q3 figures following the closing bell, with its stock price more than trebling over the past 12 months. Also recommended in _SA_ by Team Rule Breakers like CME, the company is expected to deliver further AI-led growth in advanced chip packaging. * **ServiceNow** (NOW 2.54%), recommended in _SA_ by Team Hidden Gems, has Q1 results scheduled after market close, as the company faces competitive pressure in the drive to incorporate AI in its workflow software offerings. Fool contributing analyst Jeff Santoro last month noted "if you're a company using a software for a long time ... it's really hard to rip it out and change it with something else." 4. Your Take ------------ **Shopify** (SHOP 1.37%) has dropped around 20% year to date in the recent SaaS sell-off. **Are you seeing it as a buying opportunity, holding steady if you own it, or using the weakness to trim or exit? What's shaping your view?** Debate with friends and family, or become a member to hear what your fellow Fools are saying!
0
0
0
0
MrDecoder

MrDecoder

9 ore fa
![](https://img-cdn.gateio.im/social/moments-a371e655a7-da2dd0511a-8b7abd-e5a980) Breakfast News: Tesla Headlines Q1 Earnings Season -------------------------------------------------- ### April 20, 2026 | Friday's Markets | | --- | | **S&P 500** 7,126 (+1.2%) | | **Nasdaq** 24,468 (+1.52%) | | **Dow** 49,447 (+1.79%) | | **Bitcoin** $77,452 (+2.98%) | ![](https://img-cdn.gateio.im/social/moments-3d16f78197-872568bd56-8b7abd-e5a980) Source: Image created by Jester AI. 1. Tesla Kicks Off FY2026 Earnings ---------------------------------- **Tesla** (TSLA +3.93%) is due to report its first quarter of fiscal 2026 on Wednesday, with the stock down 11% year to date. It's been picking up in April, as CEO Elon Musk makes the headlines with the upcoming SpaceX IPO – now widely expected mid-June. Analysts are predicting an uptick in Tesla profit, even after 358,000 vehicle deliveries in Q1 fell short of the expected 370,000. * **Terafab to move at "light speed":** Elon Musk has been urging haste from potential suppliers for his Terafab AI chip-making project, says Bloomberg. The joint venture between Tesla and SpaceX – intended to produce a terawatt of annual computing capacity – could cost over $25 billion in capital expenditure, analysts estimate. * **"Tesla is not valued based on how many cars it can sell this or next quarter":** Fool analyst Emily Flippen last month pointed out Tesla is "valued on optionality, the sheer breadth of what this business could become and the potential for those bets to compound into durable cash flows over decades." 2. Markets Surge to New Records ------------------------------- Despite the uncertainty regarding dealings with Iran, the S&P 500 and Nasdaq both surged to new all-time highs last week – up 4.5% and 6.8% respectively. The Dow Jones fell slightly short of a new record, but still ended the week up 3.2%. The renewed closure of the Strait of Hormuz, however, sent futures down this morning – S&P 500 and Nasdaq futures both fell around 0.5%. * **Oil prices jump:** Benchmark crude prices rose more than 6% this morning, after President Trump said the U.S. Navy had taken custody of an Iranian-flagged ship in the Gulf of Oman. West Texas Intermediate climbed above $88, with Brent Crude over $95. * **Quiet economics week:** Tuesday's March retail sales update marks the main highlight of the week, with a predicted 1.5% rise on the cards – up from 0.6% in February. Friday's consumer sentiment print for April is expected to edge up to 49. Anything under 100 indicates negative confidence. 3. Report: Google to Sign Chip Deal With Marvell ------------------------------------------------ **Alphabet**'s (GOOG +0.41%) Google is in discussion with **Marvell** (MRVL +6.25%) to build two new chips aimed at improving AI model efficiency, reported The Information over the weekend. One is a memory device to help speed up Google's tensor processing unit (TPU), while the other is a new AI-targeted TPU, the report's unnamed sources say. Marvell stock jumped over 7% in pre-market trading. * **Google ups the AI stakes:** Google TPUs are part of Alphabet's strategy to try to challenge **Nvidia**'s (NVDA +1.73%) dominance in the AI processor market – and are increasingly powering the growth of Google Cloud. The new chips could be ready for test production early next year. * **AI infrastructure:** Marvell builds the semiconductor devices that handle data connection, communication and storage within AI servers. It handles just the design work, and partners with companies like **Taiwan Semiconductor** (TSM 0.84%) for fabrication. 4. Selected Foolish Earnings This Week -------------------------------------- * **Intuitive Surgical** (ISRG 0.81%) is scheduled to report Q1 Tuesday, after the _Rule Breakers_ rec finished fiscal 2025 with a 19% revenue rise in Q4, year over year. Watch for upgrade cycle updates for the robotic surgery specialist's da Vinci 5 system – and eyes open for a higher expected tariffs impact. * **IBM** (IBM +0.00%) – recommended in _Hidden Gems_ – posts a Q1 update Wednesday, after AI competition has been putting pressure on the company's human-led COBOL consulting services. Can Claude AI cut off an important revenue source? * **Intel** (INTC +13.79%) commences its fiscal 2026 reporting Thursday, with its stock climbing strongly after the chipmaker said it's joining Elon Musk's Terafab project. Intel is up 85% in 2026 year to date. 5. Your Take ------------ **Roughly what percentage of your investment portfolio consists of index trackers? Are you happy with this allocation, and why/why not?** Discuss with friends and family, or become a member to hear what your fellow Fools are saying!
0
0
0
0